Joel White spoke with Inside Drug Pricing about the Biden Adminstration’s growing interest in value-based payments for prescription drugs. CMS’ Center for Medicare and Medicaid Innovation (CMMI) is considering testing […]
Horizon CEO, Joel White, spoke to Inside Health Policy about how the Inflation Reduction Act’s drug pricing negotiations will impact the pharmaceutical industry. Horizon Government Affairs President and Founder Joel […]
Horizon’s Brett Meeks spoke with Inside Telehealth about the recent two-year telehealth extension for standalone plans. But Brett Meeks, vice president at Horizon Government Affairs, said for now lobbyists can […]
The National Review included Horizon’s work tracking drugmakers responses to the Inflation Reduction Act’s drug pricing negotiation rule, in a recent article titled, “As Predicted, Patients Are Paying the Price […]
Horizon Government Affairs is pleased to introduce Horizon Highlights. Every month, the Horizon policy team will focus on one timely topic, breaking it down into easy-to-understand infographics.
Joel White spoke with Amy Lotven at Inside Health Policy about how Congress will address Medicaid in its end-of-the-year legislation package. Last week, Joel White, president and founder of Horizon Government […]
Horizon Government Affairs President Joel White led a post-election webinar to discuss the results (as of November 10th) of the 2022 midterms and insights into how Congress might address health […]
HGA’s CEO, Joel White, spoke with Fierce Healthcare about the impact a divided Congress could have on health policy in 2023. Republicans could use their oversight tools to scrutinize the […]
Horizon Government Affairs prepared the report linked below on key races in the 2022 midterm election and where candidates stand on health policies.
Horizon’s Joel White spoke with Nathaniel Weixel at The Hill about the provision in the Inflation Reduction Act allowing Medicare to negotiate drug prices and how it could impact the […]
Horizon’s Brett Meeks was interviewed by Bloomberg Law about the delay in appointing a new NIH director. “It’s incredibly important to have someone,” Brett Meeks, a vice president at Horizon […]
Horizon hosted a webinar for clients and friends on September 12, 2022 reviewing the Inflation Reduction Act, exploring the prescription drug provisions of the law, its implications, pitfalls and next […]